title: Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973-981.
authors.affiliation: Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, University of Montpellier, Montpellier, France louis.monnier@inserm.fr.
authors.forename: Louis
authors.initials: L
authors.lastname: Monnier
authors.affiliation: Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, University of Montpellier, Montpellier, France.
authors.forename: Claude
authors.initials: C
authors.lastname: Colette
authors.affiliation: Diabetes Research Group, Swansea University, Swansea, Wales, U.K.
authors.forename: David R
authors.initials: DR
authors.lastname: Owens
mesh_terms: D001786:Blood Glucose; D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D052216:Glucagon-Like Peptide 1; D005947:Glucose; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin; D061266:Insulin, Short-Acting; D012108:Research Personnel; D012307:Risk Factors; D000073893:Sugars
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061266:Insulin, Short-Acting; D000073893:Sugars; D052216:Glucagon-Like Peptide 1; D005947:Glucose